Hangzhou AGS MedTech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hangzhou AGS MedTech Co., Ltd.

Why is Hangzhou AGS MedTech Co., Ltd. ?

The company has declared negative results in Mar'2025 after 6 consecutive positive quarters

INTEREST(HY) At CNY 0.05 MM has Grown at 20,195.21%
OPERATING PROFIT MARGIN(Q) Lowest at 31.67 %
DEBT-EQUITY RATIO (HY) Highest at -67.42 %

With ROE of 12.05%, it has a attractive valuation with a 2.41 Price to Book Value

Over the past year, while the stock has generated a return of -16.67%, its profits have risen by 34%
At the current price, the company has a high dividend yield of 0.3

Below par performance in long term as well as near term

Along with generating -16.67% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Hangzhou AGS MedTech Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hangzhou AGS MedTech Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Hangzhou AGS MedTech Co., Ltd.

-20.93%

0.15

36.25%

China Shanghai Composite

16.01%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

21.34%

EBIT Growth (5y)

19.69%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.72

Sales to Capital Employed (avg)

0.25

Tax Ratio

14.89%

Dividend Payout Ratio

37.72%

Pledged Shares

Institutional Holding

ROCE (avg)

67.58%

ROE (avg)

11.26%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.41

EV to EBIT

13.75

EV to EBITDA

13.19

EV to Capital Employed

6.67

EV to Sales

6.02

PEG Ratio

Dividend Yield

0.30%

ROCE (Latest)

48.48%

ROE (Latest)

12.05%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 1.06% (YoY

-17What is not working for the Company

INTEREST(HY)

At CNY 0.05 MM has Grown at 20,195.21%

OPERATING PROFIT MARGIN(Q)

Lowest at 31.67 %

DEBT-EQUITY RATIO (HY)

Highest at -67.42 %

OPERATING PROFIT(Q)

Lowest at CNY 49.69 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 60.2 MM

NET PROFIT(Q)

Lowest at CNY 51.28 MM

EPS(Q)

Lowest at CNY 0.63

Here's what is working for Hangzhou AGS MedTech Co., Ltd.

Raw Material Cost

Fallen by 1.06% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hangzhou AGS MedTech Co., Ltd.

Interest

At CNY 0.05 MM has Grown at 20,195.21%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit Margin

Lowest at 31.67 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Operating Profit

Lowest at CNY 49.69 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit

Lowest at CNY 60.2 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

Fallen at -29.28%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 51.28 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit

Fallen at -29.75%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.63

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Highest at -67.42 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio